Advertisement

Topics

Latest "Calvert Laboratories, Inc" News Stories

05:21 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "Calvert Laboratories, Inc" found in our extensive news archives from over 250 global news sources.

More Information about Calvert Laboratories, Inc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Calvert Laboratories, Inc for you to read. Along with our medical data and news we also list Calvert Laboratories, Inc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Calvert Laboratories, Inc Companies for you to search.

Showing "Calvert Laboratories" News Articles 1–25 of 1,900+

Wednesday 19th September 2018

SenzaGen launches the first in vitro airway allergy test – GARDair – at ESTIV2018

Lund, September 18, 2018 - SenzaGen (Nasdaq First North: SENZA) announced today that the company will launch GARDair, the first in vitro test for airway allergies at ESTIV2018, the 20th International Congress on In Vitro Toxicology. Removing the need for animal testing and opening a completely new market, GARDair is based on the company’s proprietary GARD® technology platform. Using ge...


Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company

Abzena, plc (AIM: ABZA, Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed an antibody humanisation agreement with Tmunity Therapeutics (Tmunity), a clinical stage T cell therapy company and a leader in the development of new Chimeric Antigen Receptor T...

Profectus BioSciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09052018] Prices from USD $250

SummaryProfectus BioSciences Inc Profectus is a clinicalstage vaccine development company that designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company's products include genevax therapeutic vaccines, vesiculovax prophylactic vaccines and additional prophylactic vaccines. It uses PBS Vax technology platform for th...


Tuesday 18th September 2018

Italy Electrophysiology Devices Market Outlook to 2025 [Report Updated: 09042018] Prices from USD $4995

Italy Electrophysiology Devices Market Outlook to 2025SummaryGlobalData's new report, Italy Electrophysiology Devices Market Outlook to 2025, provides key market data on the Italy Electrophysiology Devices market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Cat...

First laboratory-grown human-skin test service, to use artifical intelligence, to provide clinical trial standard verification for cosmetic, personal hygiene and skin care products

Labskin (Innovenn Ltd.), a wholly owned subsidiary of Integumen plc., (AIM:SKIN) today announces that it has entered into a partnership with RinoLab (www.rinolab.com) to provide Labskin clients with access to an AI machine learning platform which accelerates development of cosmetics, skincare, woundcare, personal hygiene and pharmaceutical topical drug delivery products. The service is expected to...

Expedeon AG comments on recent share price development (news with additional features)

DGAP-News: Expedeon AG / Key word(s): Miscellaneous 18.09.2018 / 15:46 The issuer is solely responsible for the content of this announcement. PRESS RELEASE 18 September 2018 / Expedeon AG comments on recent share price development Heidelberg, Germany and Cambridge, UK, 18 September 2018 - Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard), said today that the management...

Tmunity Names Moji James as General Counsel and Executive Vice President

Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, today announced the appointment of Moji James to General Counsel and Executive Vice President. Ms. James formerly served as Senior Vice President, General Counsel and Co...

Boston Heart Diagnostics Announces New Scientific Advisory Board Appointments

Boston Heart Diagnostics, one of the leading disease management laboratories in the United States, is pleased to announce the company’s newly-appointed scientific advisory board. Boston Heart Diagnostics’ 2018 Scientific Advisory Board is comprised of recognized experts in their respective medical fields. Boston Heart Diagnostics’ Scientific...

inui Health Announces the First Clinical Grade Diagnostics Test Accessible to Everyone, Anywhere in the World, From Their Smartphone

As the first of its kind urine diagnostic panel to receive FDA approval, inui’s smartphone enabled platform immediately displays results of various diagnostic tests and has been validated in multiple clinical studies across the world. inui™ Health, a Silicon Valley digital health company, announced the launch of its flagship diagnostics in-h...

Aspect Biosystems Announces Liver Tissue Collaboration with JSR

Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting technologies, is pleased to announce a new collaboration to develop human liver tissue with

Kraig Biocraft Laboratories Accelerates Development of New Recombinant Spider Silk Fibers

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that it has implemented two major advancements in the development of next generation recombinant spider silk fibers. These advancements are the result of new equipment and recently employed protocols at the Company’s...

Gamida Cell Strengthens Its Board of Directors with Appointment of Robert Blum as Chairman

Gamida Cell, a leading cellular and immune therapeutics company, today announced the appointment of Robert Blum, president and chief executive officer of Cytokinetics, Inc., as chairman of Gamida Cell’s board of directors. Julian Adams, Ph.D., Gamida Cell’s chief executive officer and previous chairman, will remain on the company’s board of directors...

B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG announces strategic research collaboration with BluCon Biotech GmbH

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Strategic Company Decision 18.09.2018 / 08:59 The issuer is solely responsible for the content of this announcement. Chemicals from Renewable Resources BRAIN AG announces strategic research collaboration with BluCon Biotech GmbH Joint R&D work aims at microbial strain development for the produc...

Monday 17th September 2018

Thermo Scientific VetDrugs Explorer Collection

Food scientists can now take advantage of a start-to-finish solution that offers robust and sensitive analysis of multiresidue veterinary drugs in complex animal-derived sample matrices, helping identify animal and dairy products that may be unsafe for human consumption. The Thermo Scientific VetDrugs Explorer Collection is a single-provider, liquid chromatography-mass spectrometry/mass spectrome...

Complete Cannabis Testing Solutions for the Canadian Market from a Single Source

With the updates to Canada's cannabis laws set for implementation in October 2018, scientists operating within this highly regulated, growing market can now access an end-to-end analytical solution that aligns with the testing standards set by Health Canada. Thermo Fisher Scientific is supporting regulatory laboratories, contract research organizations and licensed dealers, producers and suppliers...

Nemaura Announces License Agreement for 3 New Transdermal Patch Developments, and 48 Hour Diclofenac Patch Debut at CPhI Madrid

Nemaura Pharma today announced it has entered into a license agreement with a Global Pharma Company to develop 3 new Transdermal Patch products. These patches address a multi-Billion dollar market and the agreement reflects the confidence placed in Nemaura’s ability to deliver complex dosage formulations. Previously Nemaura developed a daily transdermal ...

Avista Pharma Solutions Expands Service Offerings in New England

CDMO Expands Analytical Chemistry Suite and Announces New Boston Metro Office Avista Pharma Solutions, Inc. (“Avista Pharma”) has announced upgrades to its Agawam, MA facility, increasing its analytical chemistry footprint while expanding its compendial and raw material testing capabilities. In addition to these upgrades, the company has als...

Stoke Therapeutics Appoints Biotech Veteran Arthur Tzianabos, Ph.D. to Board of Directors

Stoke Therapeutics, Inc., today announced that veteran biotech executive Arthur Tzianabos, Ph.D., who has extensive experience in the development and commercialization of rare disease treatments, will join the company’s board of directors. Dr. Tzianabos, the CEO and president of Homology Medicines, joins the board as Stoke is advancing to...

Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs

Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs Deqing, China, September 17, 2018 / B3C newswire / -- Shuwen Biotech is the first in China to launch a locally manufactured proprietary PD-L1 test kit, which can accurately determine the expression status of PD-L1 in tumor tissues, and to provide laboratory te...

ATL Webcast: Top 10 Reasons to Purchase a LIMS

Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Systems (LIMS), continues the 2018 LIMS Webcast series on Wednesday, September 19th with Top 10 Reasons to Purchase a LIMS. This webcast will be ideal for organizations who know they need to automate their laboratory and want guidance on performing a needs assessment, gathering business requirements and ...

Driving real-time productivity insights with connected laboratory automation

Tecan is offering its customers unprecedented insight into how their Fluent® and Freedom EVO® liquid handing platforms are being used, thanks to its Introspect™ and Common Notification System (Tecan CNS™) software tools. As laboratories and laboratory equipment become ever more connected with the Internet of Things (IoT), this powerful combination of monitoring solutions can pr...

QIAGEN and DiaSorin Launch Automated Testing for Latent TB infection with QuantiFERON-TB Gold Plus Technology on Widely Used LIAISON Platforms

CE-marked workflow enables efficient, high-throughput screening for tuberculosis control efforts in Europe and other markets; introduction in United States expected in 2019 and China in 2020 QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE Italy Mid Cap: DIA) today announced the introduction of an automated, CE-marked workflow...

QIAGEN and NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing

QIAGEN to launch two Sample to Insight systems in Europe and other markets, NeuMoDx to commercialize in the U.S. / Initial assay menu for infectious diseases and LDTs QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced a strategic partnership to commercialize two new fully integrated systems for...

Sunday 16th September 2018

Spain Prosthetic Heart Valves Market Outlook to 2025 [Report Updated: 02042018] Prices from USD $4995

Spain Prosthetic Heart Valves Market Outlook to 2025SummaryGlobalData's new report, "Spain Prosthetic Heart Valves Market Outlook to 2025", provides key market data on the Spain Prosthetic Heart Valves market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Tissue Heart Valves, Transcatheter Heart Valves and Mechanical Heart Valv...

Orion Diagnostica Oy Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummaryOrion Diagnostica Oy Orion Diagnostica, a subsidiary of Orion Oyj, is a medical equipment company that develops, manufactures clinical diagnostic and hygiene monitoring tests. Its product portfolio provides diagnosis and treatment management kits, point of care systems, ready to use kits, portable incubators, dipslide culture tests, hygiene tests among others. The company's products find ap...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks